Extended survival of a HER-2-positive metastatic breast cancer patient with brain metastases also treated with intrathecal trastuzumab

被引：0
|
作者：
Mariantonietta Colozza
Elisa Minenza
Stefania Gori
Daniela Fenocchio
Cristina Paolucci
Cynthia Aristei
Piero Floridi
机构：
[1] Azienda Ospedaliera,S.C. Oncologia
[2] Azienda Ospedaliera,Servizio di Anatomia Patologica
[3] Azienda Ospedaliera,Laboratorio Preparazione Farmaci Antiblastici
[4] Azienda Ospedaliera,Istituto di Radioterapia
[5] Azienda Ospedaliera,S.C. Neuroradiologia
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 63卷
关键词：
Trastuzumab; Brain Metastasis; Capecitabine; Lapatinib; Metastatic Breast Cancer Patient;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1157 / 1159
页数：2
相关论文
共 50 条
  • [1] Extended survival of a HER-2-positive metastatic breast cancer patient with brain metastases also treated with intrathecal trastuzumab
    Colozza, Mariantonietta
    Minenza, Elisa
    Gori, Stefania
    Fenocchio, Daniela
    Paolucci, Cristina
    Aristei, Cynthia
    Floridi, Piero
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (06) : 1157 - 1159
  • [2] The incidence and treatment outcome after radiotherapy for brain metastases in HER-2-positive metastatic breast cancer patients treated with trastuzumab
    Arif, S.
    Barrett-Lee, P. J.
    Jordan, C.
    [J]. CLINICAL ONCOLOGY, 2006, 18 (09) : 719 - 720
  • [3] HER-2-positive metastatic breast cancer: trastuzumab and beyond
    Metro, Giulio
    Mottolese, Marcella
    Fabi, Alessandra
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (15) : 2583 - 2601
  • [4] Central nervous system metastases in HER-2-positive metastatic breast cancer patients treated with trastuzumab:: Incidence, survival, and risk factors
    Gori, Stefania
    Rimondini, Simonetta
    De Angelis, Verena
    Colozza, Mariantonietta
    Bisagni, Giancarlo
    Moretti, Gabriella
    Sidoni, Angelo
    Basurto, Carlo
    Aristei, Cynthia
    Anastasi, Paola
    Crino, Lucio
    [J]. ONCOLOGIST, 2007, 12 (07): : 766 - 773
  • [5] Extended survival in women receiving trastuzumab for brain metastases from HER2 positive metastatic breast cancer
    不详
    [J]. EJC SUPPLEMENTS, 2006, 4 (02): : 163 - 163
  • [6] Trastuzumab emtansine in the systemic treatment of HER-2-positive breast cancer brain metastases
    Frenel, Jean-Sebastien
    Bally, Olivia
    Bourbouloux, Emmanuelle
    Berton-Rigaud, Dominique
    Campone, Mario
    Bachelot, Thomas
    Heudel, Pierre-Etienne
    [J]. BULLETIN DU CANCER, 2016, 103 (05) : 507 - 510
  • [7] Trastuzumab emtansine in the treatment of HER-2-positive metastatic breast cancer patients
    Bighin, Claudia
    Pronzato, Paolo
    Del Mastro, Lucia
    [J]. FUTURE ONCOLOGY, 2013, 9 (07) : 955 - 957
  • [8] Clinical utility of continuing trastuzumab beyond brain progression in HER-2-positive metastatic breast cancer
    Metro, Giulio
    Sperduti, Isabella
    Russillo, Michelangelo
    Milella, Michele
    Cognetti, Francesco
    Fabi, Alessandra
    [J]. ONCOLOGIST, 2007, 12 (12): : 1467 - 1469
  • [9] Occult brain metastases in her-2-positive breast cancer patients
    不详
    [J]. EJC SUPPLEMENTS, 2006, 4 (02): : 164 - 164
  • [10] HER-2-positive metastatic breast cancer: Optimizing trastuzumab-based therapy
    Jackisch, Christian
    [J]. ONCOLOGIST, 2006, 11 : 34 - 41
12345